ClinConnect ClinConnect Logo
Search / Trial NCT06658574

Oral Acetaminophen for Post-Op Pain Management in Bariatric Surgery Patients

Launched by RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY · Oct 24, 2024

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Acetaminophen Bariatric Analgesia Perioperative Post Operative

ClinConnect Summary

This clinical trial is studying how well different forms of acetaminophen (a common pain reliever) work for managing pain after bariatric surgery, specifically Roux-en-Y gastric bypass or laparoscopic sleeve gastrectomy. The researchers want to find out if patients experience better pain relief when taking acetaminophen in liquid form compared to pill form, especially considering that these surgeries can change how the body processes medications.

To participate in this trial, you need to be an adult aged 18 or older who is having one of the mentioned types of weight-loss surgery. However, if you have a known allergy to acetaminophen, can't take pills, or have certain medical conditions related to pain management, you may not be eligible. If you join the study, you will help researchers learn more about effective pain control for people like you after surgery, and you will be monitored for how well each form of acetaminophen works for your pain.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Adults aged 18 years old or greater who meet patient selection criteria for either primary Roux-en-Y gastric bypass or primary laparoscopic sleeve gastrectomy.
  • Exclusion Criteria:
  • Patients with a known hypersensitivity or history of intolerance to acetaminophen or any inactive ingredients in either formulation. Patients uncomfortable with or unable to take pills.
  • Surgical: Duodenal Switch (DS) surgeries, Adjustable Gastric Banding (AGB), surgical revisions, and surgical conversions.
  • Medical: patients with documented history of chronic and/or current pain syndrome, as evidenced by documentation of ICD-10 code G89.4, patients with documented ICD-10 code F11.90, indication unspecified, uncomplicated opioid use.
  • Patients of vulnerable populations, as outlined by federal guidelines as children, prisoners, pregnant women, and mentally disabled persons will be excluded.

About Rutgers, The State University Of New Jersey

Rutgers, The State University of New Jersey, is a prestigious public research university renowned for its commitment to advancing medical science and public health. As a leading clinical trial sponsor, Rutgers leverages its extensive academic resources, cutting-edge facilities, and a diverse team of experts to conduct innovative research that addresses critical health challenges. The university fosters collaboration across disciplines, engaging in partnerships with healthcare institutions and industry leaders to enhance the development of novel therapies and improve patient outcomes. With a strong emphasis on ethical standards and regulatory compliance, Rutgers is dedicated to advancing clinical knowledge while prioritizing participant safety and well-being in all of its research endeavors.

Locations

New Brunswick, New Jersey, United States

Patients applied

0 patients applied

Trial Officials

Daniel T Abazia, PharmD, BCPS, CPPS

Principal Investigator

Rutgers University - Ernest Mario School of Pharmacy

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported